PIK3CA and cancer: Succinate secreted by tumor cells activates the PI3K/HIF-1α and ERK1/2 pathways via the SUCNR-1 receptor, thereby upregulating VEGF expression, inducing angiogenesis, and enhancing cancer cell migration (77).